These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8674569)

  • 21. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone. Analogue depot therapy.
    Cirkel U; Ochs H; Roehl A; Schneider HP
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):328-32. PubMed ID: 8160541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure.
    Bozzini N; Rodrigues CJ; Petti DA; Bevilacqua RG; Gonçalves SP; Pinotti JA
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):330-4. PubMed ID: 12716317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.
    Wilson EA; Yang F; Rees ED
    Obstet Gynecol; 1980 Jan; 55(1):20-4. PubMed ID: 7352057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
    Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
    J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment.
    Di Lieto A; De Rosa G; De Falco M; Iannotti F; Staibano S; Pollio F; Scaramellino M; Salvatore G
    Hum Pathol; 2002 Feb; 33(2):220-4. PubMed ID: 11957148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histology of leiomyomata in patients treated with leuprolide acetate.
    Demopoulos RI; Jones KY; Mittal KR; Vamvakas EC
    Int J Gynecol Pathol; 1997 Apr; 16(2):131-7. PubMed ID: 9100066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumour histology and the phase of menstrual cycle.
    Chrapusta S; Sieinski W; Konopka B; Szamborski J; Paszko Z
    Eur J Gynaecol Oncol; 1990; 11(5):381-7. PubMed ID: 2097155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy.
    Cohen D; Mazur MT; Jozefczyk MA; Badawy SZ
    J Reprod Med; 1994 May; 39(5):377-80. PubMed ID: 7520497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
    Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
    Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of insulin-like growth factor type I receptor and uterine volume changes in gonadotropin-releasing hormone analog-treated uterine leiomyomas.
    Di Lieto A; Iannotti F; De Falco M; Staibano S; Pollio F; Ciociola F; De Rosa G
    Am J Obstet Gynecol; 2003 Mar; 188(3):702-6. PubMed ID: 12634644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
    Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
    Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
    Palomba S; Affinito P; Tommaselli GA; Nappi C
    Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in insulin sensitivity during GnRH agonist treatment in premenopausal women with leiomyoma.
    Matsui S; Yasui T; Tani A; Kunimi K; Uemura H; Yamamoto S; Kuwahara A; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
    Clin Chim Acta; 2012 Jun; 413(11-12):960-5. PubMed ID: 22366120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone, estradiol and their receptors in leiomyomata and the adjacent normal myometria of black Kenyan women.
    Wango EO; Tabifor HN; Muchiri LW; Sekadde-Kigondu C; Makawiti DW
    Afr J Health Sci; 2002; 9(3-4):123-8. PubMed ID: 17298155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
    Palomba S; Pellicano M; Affinito P; Di Carlo C; Zullo F; Nappi C
    Fertil Steril; 2001 Feb; 75(2):429-33. PubMed ID: 11172852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.